Issue 1, 2022

Two dimensional nanosheets as immunoregulator improve HIV vaccine efficacy

Abstract

Two-dimensional (2D) nanosheets as carriers have shown promising potential for surface-displaying or loading various drugs. Nevertheless, developing sheet-like materials themselves into an immunoregulator has never been realized so far. In this study, we take advantage of the immunoregulatory effects of rare earth elements themselves and develop water-soluble erbium–dysprosium 2D nanosheets (2D NSs). Such 2D NSs can target lymph nodes and activate macrophages to improve vaccine efficacy in mice significantly. Transcriptome analysis further reveals that six critical molecules (Msr1, Ccr2, Serpinb9, Klrk1, Klrd1, Klrc1) closely correlate with 2D NS-mediated immunoregulation in vivo. For the first time, the present work realizes a proof-of-concept for designing immunoregulatory 2D NSs and shows a promising potential of 2D NSs for improving the immunoprophylaxis/immunotherapy of vaccines.

Graphical abstract: Two dimensional nanosheets as immunoregulator improve HIV vaccine efficacy

Supplementary files

Article information

Article type
Edge Article
Submitted
23 Jul 2021
Accepted
27 Nov 2021
First published
07 Dec 2021
This article is Open Access

All publication charges for this article have been paid for by the Royal Society of Chemistry
Creative Commons BY license

Chem. Sci., 2022,13, 178-187

Two dimensional nanosheets as immunoregulator improve HIV vaccine efficacy

Y. Liu, Y. L. Balachandran, Z. Li, Y. Cong, Y. Shao and X. Jiang, Chem. Sci., 2022, 13, 178 DOI: 10.1039/D1SC04044H

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements